July 21, 2011
Novartis Corp. and Teva Pharmaceuticals USA Inc. buried the hatchet Wednesday in a seven-year-old patent dispute in New Jersey over hypertension drug Lotrel, with a federal judge approving a settlement.
September 21, 2004
Swiss pharmaceutical company Novartis AG has sued Israeli generics maker Teva Pharmaceutical Industries Ltd. to block a generic version of its hypertension drug Lotrel.